All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

@officialharleymeds's TRT starting dose claims, fact-checked

HARLEYMEDS

TikTok creator

11.9K viewsWatch on TikTok→

Quick answer

Testosterone replacement therapy for hypogonadism is typically initiated with testosterone cypionate or enanthate in the range of 75-200mg per week, with dose titration guided by serum testosterone levels drawn at trough (before next injection) at 6-8 weeks post-initiation. The Endocrine Society recommends targeting mid-normal range testosterone levels rather than a fixed milligram dose, with concurrent monitoring of hematocrit, estradiol, and PSA depending on patient profile. The creator's described escalation from 90mg to 180mg over multiple three-month cycles lacks any stated lab-based rationale, which is a meaningful omission in a video framed as dosing guidance.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @officialharleymeds actually say?

The creator shared their personal TRT journey, noting they began at 90mg per week and gradually increased to 180mg over time. They then generalized from their own experience, claiming "most of the guys I see get prescribed" somewhere between 100 and 150 milligrams per week as a starting dose for TRT-naive patients. The video ends with an engagement prompt asking viewers about their own starting doses.

To be clear about what this is: one person sharing anecdotal experience and informal observations from their social circle. There is no clinical context provided, no mention of lab values, no discussion of the underlying diagnosis driving the prescription, and no acknowledgment that dosing in testosterone replacement is supposed to be guided by bloodwork, not round numbers.

Does the science back this up?

Partially, yes. The 100-150mg per week range the creator cites does roughly align with common clinical practice for testosterone cypionate or enanthate, but that alignment is somewhat coincidental. The actual clinical picture is more nuanced than the video suggests.

The Endocrine Society's 2018 clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend doses titrated to achieve mid-normal range serum testosterone levels, typically 400-700 ng/dL in most guidelines, rather than targeting a fixed weekly milligram number. A 2020 review by Corona et al. in the journal Andrology found substantial individual variability in pharmacokinetics, meaning the same 100mg dose produces meaningfully different serum levels across patients based on body composition, injection frequency, and metabolism. Starting at a fixed dose without follow-up bloodwork at 6-8 weeks is, frankly, how men end up either undertreated or pushing hematocrit into problematic territory.

What did they get wrong (or right)?

They got the ballpark right but missed the reasoning that makes that ballpark meaningful. The 100-150mg range is not a universal starting point. It is a rough clinical convention that exists specifically because it tends to produce therapeutic serum levels in a reasonable proportion of men, with the expectation that dose adjustments follow lab results.

The creator's own trajectory, 90mg escalating to 180mg over repeated three-month intervals, actually illustrates the titration process correctly in practice, even if it is framed as a personal story rather than a clinical protocol. What is missing entirely is any mention of hematocrit monitoring, estradiol management, or the fact that 180mg per week is meaningfully above what most endocrinology guidelines would call standard replacement dosing. A 2019 study by Ramasamy et al. in Translational Andrology and Urology noted that doses above 150mg per week are often associated with higher erythrocytosis risk, which requires monitoring.

  • Credit where it is due: acknowledging individual variability is accurate and important.
  • The omission of any lab-based titration framework is a significant gap for a video about dosing.
  • Framing 180mg as being "fully optimized" without clinical context is imprecise at best.

What should you actually know?

TRT dosing is not a starting number you pick and increment on a schedule. It is a process driven by baseline and follow-up bloodwork, specifically total testosterone, free testosterone, hematocrit, estradiol, and PSA in older men. The Endocrine Society guidelines are explicit that the goal is serum testosterone levels, not a weekly milligram target.

The 100-150mg per week figure circulates widely in online TRT communities and does reflect common prescribing practice, but "common" and "correct for you" are different things. A 2021 analysis by Mulhall et al. in the Journal of Sexual Medicine found that a significant proportion of men on TRT are either over- or under-dosed when dosing decisions are not supported by regular monitoring. If a provider is adjusting your dose on a fixed three-month schedule without lab values driving those decisions, that is worth asking questions about. Bloodwork, not a calendar, should drive titration.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @officialharleymeds's TRT starting dose claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@officialharleymeds's TRT starting dose claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

Use the health tools and supporting evidence to prepare questions for your clinician.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Testosterone replacement therapy for hypogonadism is typically initiated with testosterone cypionate or enanthate in the range of 75-200mg per week, with dose titration guided by serum testosterone levels drawn at trough (before next injection) at 6-8 weeks post-initiation.

FormBlends verdict

Testosterone replacement therapy for hypogonadism is typically initiated with testosterone cypionate or enanthate in the range of 75-200mg per week, with dose titration guided by serum testosterone levels drawn at trough (before next injection) at 6-8 weeks post-initiation. The Endocrine Society recommends targeting mid-normal range testosterone levels rather than a fixed milligram dose, with concurrent monitoring of hematocrit, estradiol, and PSA depending on patient profile. The creator's described escalation from 90mg to 180mg over multiple three-month cycles lacks any stated lab-based rationale, which is a meaningful omission in a video framed as dosing guidance.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Testosterone replacement therapy for hypogonadism is typically initiated with testosterone cypionate or enanthate in the range of 75-200mg per week, with dose titration guided by serum testosterone levels drawn at trough (before next injection) at 6-8 weeks post-initiation. The Endocrine Society recommends targeting mid-normal range testosterone levels rather than a fixed milligram dose, with concurrent monitoring of hematocrit, estradiol, and PSA depending on patient profile. The creator's described escalation from 90mg to 180mg over multiple three-month cycles lacks any stated lab-based rationale, which is a meaningful omission in a video framed as dosing guidance.
  • The Endocrine Society (Bhasin et al., 2018, JCEM) recommends targeting mid-normal serum testosterone levels of roughly 400-700 ng/dL, not a fixed weekly milligram dose.
  • 100-150mg per week is a common starting convention for testosterone cypionate or enanthate, but individual pharmacokinetics mean the same dose produces meaningfully different blood levels across patients (Corona et al., 2020, Andrology).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The Endocrine Society (Bhasin et al., 2018, JCEM) recommends targeting mid-normal serum testosterone levels of roughly 400-700 ng/dL, not a fixed weekly milligram dose.
  • 100-150mg per week is a common starting convention for testosterone cypionate or enanthate, but individual pharmacokinetics mean the same dose produces meaningfully different blood levels across patients (Corona et al., 2020, Andrology).
  • Doses above 150mg per week are associated with increased erythrocytosis risk and require hematocrit monitoring, a safety consideration absent from this video (Ramasamy et al., 2019, Translational Andrology and Urology).
  • Trough bloodwork at 6-8 weeks post-initiation, not a fixed calendar schedule, should drive dose titration decisions according to standard clinical guidelines.
  • A significant proportion of men on TRT are over- or under-dosed when decisions are made without regular lab monitoring, according to Mulhall et al. (2021, Journal of Sexual Medicine).
  • The term 'fully optimized' has no standardized clinical definition and should not be interpreted as a dosing endpoint without reference to actual lab values.
  • Estradiol, PSA in appropriate patients, and hematocrit monitoring are part of responsible TRT management and were not mentioned in this video's dosing discussion.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

HARLEYMEDS · TikTok creator

11.9K views on this video

Starting dose of TRT Testosterone Replacement Therapy #Trt #trtgains #trt101 #trtfamily #trttransformation #trtshots #trtshot #trtforlife #trtdays #trtcommunity #trtbeforeandafter #trtlife #trtgai

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by HARLEYMEDS, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.